Two Chinese Companies Listed on FDA Red List for Frog Legs and Dried Cabbages
In recent news, two Chinese companies have been included in the FDA's (Food and Drug Administration) red list, which highlights imports subject to cautionary measures. The products involved in this listing are frog legs and dried cabbages. This development has raised concerns regarding the safety and compliance of these food items in the international market.
The FDA recently updated its import alert measures, and among them, it has implemented automatic detention for products associated with two Chinese companies. This action signifies potential risks associated with the quality or safety of these products. The companies affected by this red listing are Shantou Freezing Aquatic Product Foodstuffs Co., based in Guangdong, and Pang Li Trading Co., based in Hong Kong.
Specifically, Shantou Freezing Aquatic Product Foodstuffs Co. has had its frog legs product flagged for containing sulfamethazine, a substance that raises concerns due to its potential health risks. On the other hand, Pang Li Trading Co.'s dried cabbages were found to contain bromophos, pyrimethanil, azoxystrobin, and cyprodinil, all of which are substances that pose potential hazards to consumers.
Import alerts serve as a preventive measure by the FDA for imported food products with potential risks. Under these alerts, products meeting the criteria are automatically detained without inspection. It is important to note that automatic detention does not necessarily imply that the exported products do not meet the import standards of the United States. Products subject to automatic detention must undergo testing by FDA-approved laboratories and receive approval from local FDA branches before being released for sale in the U.S. market.
The inclusion of these Chinese companies and their respective products on the FDA's red list highlights the importance of adhering to the import requirements of destination countries and conducting thorough inspections to ensure compliance with food safety regulations. Exporting companies should be diligent in checking for pesticide and veterinary drug residues in their products to mitigate the risk of detention and protect their reputation in international markets.
In conclusion, the listing of two Chinese companies on the FDA's red list for their frog legs and dried cabbages underscores the significance of food safety and compliance in international trade. It serves as a reminder for companies to strictly adhere to import regulations, conduct thorough product inspections, and ensure the absence of harmful substances in their food products. By prioritizing safety and compliance, companies can maintain consumer trust and facilitate smoother trade relationships with importing countries.
2026-09-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
Recommend Reading
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
FDA Tracks Industry Dye Removal
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
Cost Support Drives Slight Rise in Toluene Market in January
-
Costs Strongly Support, China's Gasoline and Diesel Prices Surge
-
Support Effective, January Normal Butanol Market Price Increase Exceeds 18% in China
-
Positive Factors Support January Price Increase of Cyclohexanone in Shandong by Nearly 9%
-
In February, the market price center of anhydrous hydrogen fluoride in China moved upward